Psychiatry and Neurology, Neurology · Saint Louis, MO
NPI
1558426619
Since 2006
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
4921 Parkview Pl, Div Neurology Multiple Sclerosis, 7th Fl
Saint Louis, MO, 63110
Phone (314) 362-3293
Groups this clinician bills Medicare through
Medicare paid, 2024
$5,092
74 services
Medicare patients, 2024
45
Average age 63
Drug cost, 2024
$1.4M
572 prescriptions
Company payments, 2025
$26K
From 7 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Gregory F Wu was code 99215 (office e&m - established), 25 times for 22 patients. In total Gregory F Wu billed 74 services in 13 codes, and Medicare paid $5,092.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-02-03.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Office | 25 | 22 | $100.79 | $2,520 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 22 | 20 | $11.46 | $252 |
By year: 2022 $5,845 for 59 services; 2023 $6,517 for 66 services; 2024 $5,092 for 74 services.
Medicare prescription drug claims, 2024
In 2024, the drug Gregory F Wu prescribed most often to Medicare patients was Baclofen, with 57 prescriptions and refills. In total Gregory F Wu wrote 572 Medicare prescriptions that cost $1.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Baclofen Generic | 57 | 86 | 14 | $1,975 |
| Dalfampridine Er Dalfampridine | 51 | 51 | Under 11 | $12K |
| Gabapentin Generic | 37 | 61 | Under 11 | $1,172 |
| Octagam Immun Globg(Igg)/Malt/Iga Ov50 | 36 | 36 | Under 11 | $329K |
| Dimethyl Fumarate Generic | 30 | 30 | Under 11 | $3,861 |
| Teriflunomide Generic | 26 | 26 | Under 11 | $1,167 |
| Pregabalin Generic | 25 | 27 | Under 11 | $2,526 |
| Amitriptyline Hcl Generic | 22 | 38 | Under 11 | $318 |
| Tizanidine Hcl Generic | 21 | 39 | Under 11 | $450 |
| Plegridy Pen Peginterferon Beta-1a | 21 | 23 | Under 11 | $189K |
| Glatopa Glatiramer Acetate | 17 | 17 | Under 11 | $28K |
| Amantadine Amantadine Hcl | 17 | 49 | Under 11 | $1,350 |
| Duloxetine Hcl Generic | 16 | 26 | Under 11 | $536 |
| Vumerity Diroximel Fumarate | 15 | 15 | Under 11 | $150K |
| Copaxone Glatiramer Acetate | 14 | 14 | Under 11 | $80K |
Brand drugs: 120 claims; generic drugs: 452 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Gregory F Wu $26K ($21K in general payments such as food, travel and fees and $4,293 for research) from 7 companies. The largest payer was EMD Serono, Inc. with $8,327.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.